Similar articles

• Hyaluronidase in subcutaneous infusion of fluid.

  LENSTRUP J. LENSTRUP J. Acta Pharmacol Toxicol (Copenh). 1951;7(2):143-52. Acta Pharmacol Toxicol (Copenh). 1951. PMID: 14846663 No abstract available.
• Effect of cortisone on the subfascial spread of fluid in mice.

  SCHMIDT A. SCHMIDT A. Acta Pharmacol Toxicol (Copenh). 1956;12(2):171-4. doi: 10.1111/j.1600-0773.1956.tb01373.x. Acta Pharmacol Toxicol (Copenh). 1956. PMID: 13339383 No abstract available.
• [Fractionated analysis of tissue juice. II. Volume, cell content and potassium level of the tissue juice, with reference to the effect of hyaluronidase].

  BARTELHEIMER H, STEINORTH G, OLK W. BARTELHEIMER H, et al. Z Gesamte Exp Med. 1951;118(2):109-22. Z Gesamte Exp Med. 1951. PMID: 13029633 Undetermined Language. No abstract available.
• Overview of recombinant human hyaluronidase-facilitated subcutaneous infusion of IgG in primary immunodeficiencies.

  Wasserman RL. Wasserman RL. Immunotherapy. 2014;6(5):553-67. doi: 10.2217/imt.14.34. Immunotherapy. 2014. PMID: 24896624 Review.
• Recombinant human hyaluronidase-facilitated subcutaneous immunoglobulin infusion in primary immunodeficiency diseases.

  Wasserman RL. Wasserman RL. Immunotherapy. 2017 Sep;9(12):1035-1050. doi: 10.2217/imt-2017-0092. Epub 2017 Sep 5. Immunotherapy. 2017. PMID: 28871852 Review.